Antileishmanial agent-35
Antileishmanial agent-35 (Compound 6) is an antileishmanial agent with an IC50 of 0.29μM for promastigotes of Leishmania amazonensis. Antileishmanial agent-35 significantly decreases the mitochondrial membrane potential and ATP levels, and further increases the production of ROS by a blockage in the electron transport chain, where ubiquinone intervenes. Antileishmanial agent-35 can be used for cutaneous leishmaniases research[1].
Product Specifications
CAS Number
100611-91-4
UNSPSC
12352005
Target
Mitochondrial Metabolism; Parasite; Reactive Oxygen Species (ROS)
Related Pathways
Anti-infection; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Field of Research
Infection
Smiles
O=C1C(C2CCCCC2)=CC(C(C)=C1)=O
Molecular Formula
C13H16O2
Molecular Weight
204.26
References & Citations
[1]García-Davis S, et al. Laurequinone-based synthetic quinones as agents against Leishmania amazonensis. Bioorg Chem. 2025 Sep;164:108897.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Leishmania
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Pyrococcus abyssi Lysine--tRNA ligase (lysS), partial
